As regulator prepares to approve Lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’
They have to recoup their costs somehow. Their licence will expire after a while and other companies and make the product and therefore brigdown the price.
Well that’ll never happen - not when the drug companies can sell $2000 a month or die medication to the inflicted for the rest of their lives.
They have to recoup their costs somehow. Their licence will expire after a while and other companies and make the product and therefore brigdown the price.